Leadership Team

The Shionogi Inc. leadership team has decades of combined pharmaceutical and industry experience in developing and commercializing therapeutics.

Focused on Solutions

Since 2011, when Shionogi Inc. was established in the U.S., our leadership team has focused on bringing the benefits of Shionogi’s small molecule drug innovations to U.S. patients through our own efforts and through multiple inventive collaborations. During this period, Shionogi Inc. gained our first two New Chemical Entity (NCE) approvals while reshaping our business around our science-based heritage and core areas of infectious diseases and pain.

Executive Leadership Committee

Senior Leadership Team

  • James Hackworth, Ph.D.

    Senior Vice President, Corporate Development and Commercialization Strategy

  • Katsura Kasahara, M.Pharm

    Senior Vice President, Clinical Development

  • Gareth Morgan

    Gareth Morgan

    Senior Vice President Head, Global Portfolio Management

  • Den Nagata M.D.

    Senior Vice President, Medical Science and Chief Medical Officer

  • Corrado Altomare, M.D.

    Vice President, U.S. Medical Affairs

  • Haixiao Chen Portrait

    Haixiao Chen

    Vice President, Product Safety & Pharmacovigilance

  • Ting Chen

    Vice President, Regulatory Affairs

  • Lynn Dale

    Vice President, Supply Chain

  • Carlos Tessi, M.D.

    Vice President, Compliance